InvestorsHub Logo
Followers 13
Posts 559
Boards Moderated 0
Alias Born 12/31/2012

Re: None

Wednesday, 08/19/2020 6:00:43 PM

Wednesday, August 19, 2020 6:00:43 PM

Post# of 5070
I believe not having any Galidesivir news by now is very bullish. The negative news delivered today on blood plasma is a good example why. Blood plasma is a poor COVID-19 therapeutic so the negative news was delivered fast. If Gali was a bust verses COVID-19 we would have heard the negative news by now. Instead, it is BCRX Crickets & the Gali COVID-19 primate & human clinical trials continue because the drug works, IMO.

Remember that Galidesivir is a broad spectrum antiviral & has done well verses multiple viruses including Ebola & Zika. COVID-19 will soon be added to the Gali list:

https://ir.biocryst.com/node/21441/pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCRX News